BNB PLUS CORP. (BNBX) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US03815U6073
BNB PLUS CORP. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.14 m USD |
| Gross profit | 838,907.00 USD |
| Operating income | -16.05 m USD |
| EBIT | -16.23 m USD |
| Net income | -15.16 m USD |
| Diluted EPS – continuing operations | -134.23 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About BNB PLUS CORP.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.
More stocks
- NovelStem International Corp. (NSTM)
- Trinseo PLC (TSEOQ)
- Professional Diversity Network, Inc. (IPDN)
- Radiant Strategies Corp (RDSC)
- Regenerative Medical Technology Group Inc. (RMTG)
- Cuentas Inc. (CUEN)
- Cheer Holding, Inc. (CHR)
- Ocean Thermal Energy Corp (CPWR)
- AUDDIA INC. (AUUD)
- REGIONAL HEALTH PROPERTIES, INC (RHEPA)
- GROOVE BOTANICALS INC. (GRVE)
- Wright Investors Service Holdings, Inc. (IWSH)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.